Skip to main content
PMC home page
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1958 Sep 30;108(4):515–535. doi: 10.1084/jem.108.4.515

AN ALTERNATIVE MECHANISM FOR THE PROPERDIN SYSTEM

Robert A Nelson Jr 1
PMCID: PMC2136897  PMID: 13575682

Abstract

Evidence is presented that phenomena ascribed to the properdin system may be explained in terms of classical antibody (Ab) in combination with three of the components of complement (C'), i.e., C'1, C'4, and C'2 respectively. The results suggest that the complex of properdin (P) with zymosan (Z) represents a mixture of Z·Ab, Z·Ab·C'1, 4, Z·Ab-C'1, 4, 2, and Z·Ab·C'1, 4, 2 in a decayed state. The purported preferential reactivity of Z with the third component of C' (C'3) is not supported by the present experiments in which Z was reacted with C' in both guinea pig and human sera. Approximately the same number of reactive units of C'1, 4 and of C'3 were inactivated by Z, as well as by D. pneumoniae and a washed specific precipitate of bovine albumin-anti-albumin. The latter evidence that small amounts of antigen-antibody complex fix significant amounts of C'3 stands in contrast with the classical concept that C'3 is not fixed in ordinary complement fixation reaction. The observed reactivity of C'3 is explained on the basis of the present use of essentially undiluted serum as a source of C'3 and of 37° as the temperature for fixation. Ancillary data indicate that purified properdin contains Ab. In the presence of a chelating agent and at 0° properdin agglutinated Z granules. Measurements of nitrogen (N) uptake by Z suggest that 0.25 µg. N were contributed by solutions stated to contain 1 unit of properdin. The broad spectrum of reactivity or cross-reactivity of the Ab in normal serum is likely due to the wide distribution in nature of closely related polysaccharides. Further immunochemical studies are necessary to establish definitively the origin and mode of action in "natural resistance" of antibodies reactive with these polysaccharides.

Full Text

The Full Text of this article is available as a PDF (1.1 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. CORDOBA F., HEIDELBERGER M. Cross-reactions of antityphoid and antiparatyphoid B horse sera with various polysaccharides. J Exp Med. 1956 Sep 1;104(3):375–382. doi: 10.1084/jem.104.3.375. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. HERBUT P. A., KRAEMER W. H. The possible role of the properdin system in transplantable cancer; the effect of zymosan on transplantable human carcinoma. Cancer Res. 1956 Dec;16(11):1048–1052. [PubMed] [Google Scholar]
  3. HINZ C. F., Jr, JORDAN W. S., Jr, PILLEMER L. The properdin system and immunity. IV. The hemolysis of erythrocytes from patients with paroxysmal nocturnal hemoglobinuria. J Clin Invest. 1956 May;35(5):453–457. doi: 10.1172/JCI103296. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. LANDY M., PILLEMER L. Elevation of properdin levels in mice following administration of bacterial lipopolysaccharides. J Exp Med. 1956 Jun 1;103(6):823–833. doi: 10.1084/jem.103.6.823. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. LEVINE L., MAYER M. M. Kinetic studies on immune hemolysis. V. Formation of the complex EAC'x and its reaction with C'y. J Immunol. 1954 Dec;73(6):426–434. [PubMed] [Google Scholar]
  6. LEVINE L., MAYER M. M., RAPP H. J. Kinetic studies on immune hemolysis. VI. Resolution of the C'y reaction step into two successive processes involving C'2 and C'3. J Immunol. 1954 Dec;73(6):435–442. [PubMed] [Google Scholar]
  7. MAYER M. M., LEVINE L., RAPP H. J., MARUCCI A. A. Kinetic studies on immune hemolysis. VII. Decay of EAC'1, 4, 2, fixation of C'3, and other factors influencing the hemolytic action of complement. J Immunol. 1954 Dec;73(6):443–454. [PubMed] [Google Scholar]
  8. MAYER M. M. Studies on the mechanism of hemolysis by antibody and complement. Prog Allergy. 1958;5:215–270. [PubMed] [Google Scholar]
  9. NELSON R. A., Jr, LEBRUN J. The requirement for antibody and complement for in vitro phagocytosis of starch granules. J Hyg (Lond) 1956 Mar;54(1):8–19. doi: 10.1017/s0022172400044259. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. PILLEMER L., BLUM L., LEPOW I. H., ROSS O. A., TODD E. W., WARDLAW A. C. The properdin system and immunity. I. Demonstration and isolation of a new serum protein, properdin, and its role in immune phenomena. Science. 1954 Aug 20;120(3112):279–285. doi: 10.1126/science.120.3112.279. [DOI] [PubMed] [Google Scholar]
  11. RAPP H. J. Mechanism of immune hemolysis: recognition of two steps in the conversion of EAC' 1,4,2 to E. Science. 1958 Jan 31;127(3292):234–236. doi: 10.1126/science.127.3292.234-a. [DOI] [PubMed] [Google Scholar]
  12. Van Vunakis H., Barlow J. L., Levine L. NEUTRALIZATION OF BACTERIOPHAGE BY THE PROPERDIN SYSTEM. Proc Natl Acad Sci U S A. 1956 Jul;42(7):391–394. doi: 10.1073/pnas.42.7.391. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES